United States · 
Who invested in Kelonia Therapeutics?
Kelonia Therapeutics's investors include Venrock and Horizons Ventures.
United States · Series A startup
Who invested in Kelonia Therapeutics
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $50MApr 2022
- Investors
- 2
The rounds
- Apr 2022
Founders and team
From Kelonia Therapeutics's own website and the SEC filings it signed: 4 on the team.
- Travis QuigleyChief Development Officer
- Scott CurrenceVP, Clinical Development Operations
- Stacy GilroyVP, Operations
- Kevin FriedmanExecutive Officer, Directori
On the board, as filediBob MoreBryan RobertsMichael BirnbaumMichael Fischbach
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Kelonia Therapeutics
How much has Kelonia Therapeutics raised?
Kelonia Therapeutics has raised $50M across 1 round since 2022.
When did Kelonia Therapeutics last raise?
Kelonia Therapeutics's most recent round was a Series A of $50M in Apr 2022.
What was Kelonia Therapeutics's biggest round?
Its most recent round, $50M in Apr 2022, is also its largest on record.
Who backed Kelonia Therapeutics first?
Kelonia Therapeutics's first round on record, in Apr 2022, was backed by Venrock and Horizons Ventures.
What stage is Kelonia Therapeutics at?
Kelonia Therapeutics's latest named round is a Series A, in Apr 2022.
Where is Kelonia Therapeutics based?
Kelonia Therapeutics is based in the United States.
Companies like Kelonia Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.